A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for Cancer Harboring BRAF Alterations
29 locations incl. Beverly Hills
Sponsor: Fore Biotherapeutics
Sex: All·Age: 10+
Code: NCT05503797·Phase 2·Recruiting·Listed Aug 2022